Goldman Sachs Group, Inc. (The) set a €73.00 ($83.91) price target on Gerresheimer AG (ETR:GXI) in a research report sent to investors on Friday morning. The brokerage currently has a neutral rating on the stock.

Other equities research analysts also recently issued reports about the stock. Hauck & Aufhaeuser set a €80.00 ($91.95) price target on shares of Gerresheimer AG and gave the company a neutral rating in a research note on Friday. Deutsche Bank AG set a €82.00 ($94.25) price target on shares of Gerresheimer AG and gave the company a buy rating in a research note on Friday. Kepler Capital Markets set a €70.00 ($80.46) price target on shares of Gerresheimer AG and gave the company a sell rating in a research note on Thursday. Berenberg Bank set a €83.00 ($95.40) price target on shares of Gerresheimer AG and gave the company a buy rating in a research note on Thursday. Finally, Commerzbank Ag set a €73.00 ($83.91) price target on shares of Gerresheimer AG and gave the company a neutral rating in a research note on Monday, June 26th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. The company has an average rating of Hold and a consensus price target of €80.06 ($92.02).

Shares of Gerresheimer AG (ETR:GXI) traded up 2.52% during trading on Friday, hitting €71.69. 250 shares of the company’s stock were exchanged. The stock’s 50-day moving average price is €74.42 and its 200-day moving average price is €73.18. The stock has a market cap of €2.25 billion and a PE ratio of 19.09. Gerresheimer AG has a 1-year low of €64.00 and a 1-year high of €79.47.

TRADEMARK VIOLATION NOTICE: This article was first reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.dailypolitical.com/2017/07/17/gerresheimer-ag-etrgxi-given-a-73-00-price-target-at-goldman-sachs-group-inc-the.html.

About Gerresheimer AG

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings.

Analyst Recommendations for Gerresheimer AG (ETR:GXI)

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.